473 results on '"Matías-Guiu, Jorge"'
Search Results
2. European cross-cultural neuropsychological test battery (CNTB) for the assessment of cognitive impairment in multiple sclerosis: Cognitive phenotyping and classification supported by machine learning techniques
3. Cognitive dysfunction characteristics of multiple sclerosis with aging
4. Thermosensitive chitosan-based hydrogel: A vehicle for overcoming the limitations of nose-to-brain cell therapy
5. Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome
6. GA-MADRID: design and validation of a machine learning tool for the diagnosis of Alzheimer’s disease and frontotemporal dementia using genetic algorithms
7. Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach
8. Predominance of visuoconstructive impairment after mild COVID-19?
9. Comparison of the Diagnostic Accuracy of Five Cognitive Screening Tests for Diagnosing Mild Cognitive Impairment in Patients Consulting for Memory Loss.
10. Identification of the main components of spontaneous speech in primary progressive aphasia and their neural underpinnings using multimodal MRI and FDG-PET imaging
11. Biocompatibility of ferulic/succinic acid-grafted chitosan hydrogels for implantation after brain injury: A preliminary study
12. Reading prosody in the non-fluent and logopenic variants of primary progressive aphasia
13. Detection of cerebrospinal fluid biomarkers changes of Alzheimer's disease using a cognitive stress test in persons with subjective cognitive decline and mild cognitive impairment.
14. Normative Data in Cross-Cultural Neuropsychological Instruments in Spaniards and Colombians Living in Spain
15. FDG-PET-based neural correlates of Addenbrooke’s cognitive examination III scores in Alzheimer’s disease and frontotemporal degeneration
16. Machine learning in the clinical and language characterisation of primary progressive aphasia variants
17. Abnormal functional connectivity in radiologically isolated syndrome: A resting-state fMRI study
18. Evaluation of the Safety and Efficacy of the Therapeutic Potential of Adipose-Derived Stem Cells Injected in the Cerebral Ischemic Penumbra
19. Inhibition impairment in frontotemporal dementia, amyotrophic lateral sclerosis, and Alzheimer’s disease: clinical assessment and metabolic correlates
20. Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis
21. In Vitro Effects of Methylprednisolone over Oligodendroglial Cells: Foresight to Future Cell Therapies
22. Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease
23. Reading difficulties in primary progressive aphasia in a regular language-speaking cohort of patients
24. Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints
25. FDG-PET-based neural correlates of Addenbrooke's cognitive examination III scores in Alzheimer's disease and frontotemporal degeneration.
26. Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience
27. Validation of the Lille's Apathy Rating Scale in Very Mild to Moderate Dementia
28. Multi-Disease Validation of the RUDAS for Cognitive Screening in Alzheimer’s Disease, Parkinson’s Disease, and Multiple Sclerosis
29. Validation of the cross-cultural dementia screening test in Alzheimer’s disease and Parkinson’s disease
30. Structural MRI correlates of PASAT performance in multiple sclerosis
31. Neuropsychological, Metabolic, and Connectivity Underpinnings of Semantic Interference Deficits Using the LASSI-L
32. Coronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study)
33. Validation of a brief cross-cultural cognitive screening test in Multiple Sclerosis
34. Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach
35. Fatigue and Cognitive Dysfunction Are Associated with Occupational Status in Post-COVID Syndrome
36. Nose-to-Brain: The Next Step for Stem Cell and Biomaterial Therapy in Neurological Disorders
37. Predominance of visuoconstructive impairment after mild COVID-19?
38. Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis
39. Neural basis of visuospatial tests in behavioral variant frontotemporal dementia
40. Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis
41. Neuropsychological Predictors of Fatigue in Post-COVID Syndrome
42. Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
43. Validation of two new scales for the assessment of fatigue in Multiple Sclerosis: F-2-MS and FACIT-F
44. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study
45. Teaching NeuroImages: Adult-onset leukoencephalopathy with intracranial calcifications and cysts (Labrune syndrome)
46. Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes
47. Visual and statistical analysis of 18F-FDG PET in primary progressive aphasia
48. Clinical course of primary progressive aphasia: clinical and FDG-PET patterns
49. Persistent olfactory dysfunction after COVID‐19 is associated with reduced perfusion in the frontal lobe
50. The Integration of Cell Therapy and Biomaterials as Treatment Strategies for Remyelination
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.